Buscar
Insulet Corp
PODDAñadir a la lista de seguimiento
165.350USD
-0.330-0.20%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
11.45BCap. mercado
38.36P/E TTM
Más Datos de Insulet Corp Compañía
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.
Información de Insulet Corp
Símbolo de cotizaciónPODD
Nombre de la empresaInsulet Corp
Fecha de salida a bolsaMay 15, 2007
Director ejecutivoMcevoy (Ashley)
Número de empleados3900
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 15
Dirección100 Nagog Park
CiudadACTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01720-3440
Teléfono19786007000
Sitio Webhttps://www.omnipod.com
Símbolo de cotizaciónPODD
Fecha de salida a bolsaMay 15, 2007
Director ejecutivoMcevoy (Ashley)
Ejecutivos de Insulet Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
29.36K
+5.65%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
19.92K
+8.33%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
16.55K
-4.75%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
10.35K
+33.33%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
8.67K
+32.17%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
6.75K
+22.59%
Ms. Laetitia Cousin
Ms. Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
5.36K
+35.90%
Dr. Luciana Borio, M.D.
Dr. Luciana Borio, M.D.
Independent Director
Independent Director
3.55K
-11.77%
Mr. Prem Singh
Mr. Prem Singh
Senior Vice President - Global Operations
Senior Vice President - Global Operations
3.11K
-123.87%
Mr. Timothy J. (Tim) Scannell
Mr. Timothy J. (Tim) Scannell
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
29.36K
+5.65%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
19.92K
+8.33%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
16.55K
-4.75%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
10.35K
+33.33%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
8.67K
+32.17%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
6.75K
+22.59%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Insulet Corp?
Los cinco principales accionistas de Insulet Corp son: Dr. Jessica Hopfield, Ph.D.
¿Cuántas instituciones poseen acciones de Insulet Corp (PODD)?
A fecha de 2026Q1, 1624 instituciones poseen acciones de Insulet Corp, con un valor de mercado combinado de aproximadamente 73.18M, lo que representa el 105.65% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -1617450.00.
¿Cuál es la mayor fuente de ganancias de Insulet Corp?
El 2026Q1, el segmento empresarial U.S.Omnipod generó la ganancia más alta para Insulet Corp, ascendiendo a 1.92B y representando el 70.89% de la ganancia total.